Eapa2 Inhibitors
Eapa2 inhibitors are a class of chemical compounds known for their specific action on the enzyme Eapa2, a protein that plays a crucial role in cellular signaling pathways. These inhibitors function by binding to the active site or an allosteric site of Eapa2, thereby blocking its enzymatic activity and affecting its downstream signaling processes. Structurally, Eapa2 inhibitors exhibit diverse chemical scaffolds, allowing for a range of binding affinities and specificities. Their structures can vary from small organic molecules to larger peptide-based compounds, designed to interact precisely with the enzyme's binding pocket. This versatility in chemical structure allows for nuanced modulation of Eapa2's function, with some inhibitors demonstrating high specificity for Eapa2 over closely related enzymes. The inhibitory mechanism often depends on the nature of the inhibitor, with reversible and irreversible binding modes being observed.
The biological relevance of Eapa2 inhibitors lies in their ability to modulate pathways that are otherwise regulated by the Eapa2 enzyme. Inhibition of Eapa2 can lead to altered phosphorylation states of various cellular substrates, impacting a range of cellular processes such as signal transduction, cell cycle progression, and metabolic regulation. The specificity of these inhibitors often depends on their molecular configuration, allowing for selective targeting of Eapa2 without significantly affecting other enzymes in the same family. In research settings, Eapa2 inhibitors are valuable tools for studying the role of Eapa2 in cell biology, providing insights into how the enzyme's activity influences cellular responses to environmental stimuli. Moreover, their ability to regulate Eapa2 activity has been pivotal in advancing our understanding of the enzyme's function within complex signaling networks, offering a window into the intricate control mechanisms within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | $109.00 $228.00 | 9 | |
Inhibits the Na-K-Cl cotransporter (NKCC), indirectly impacting Tcaf3 by disrupting ion homeostasis. Bumetanide inhibits NKCC, leading to altered ion concentrations, and subsequently influencing Tcaf3's predicted transmembrane transporter binding activity and its involvement in regulating anion channel activity. | ||||||
DIDS, Disodium Salt | 67483-13-0 | sc-203919A sc-203919B sc-203919 sc-203919C | 25 mg 100 mg 250 mg 1 g | $51.00 $163.00 $286.00 $683.00 | 6 | |
Inhibits chloride channels, indirectly influencing Tcaf3 through modulation of anion transport. DIDS disrupts chloride channel activity, impacting the cellular environment and subsequently affecting Tcaf3's predicted negative regulation of anion channel activity. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
Blocks store-operated calcium channels (SOCCs), indirectly impacting Tcaf3 by modulating calcium signaling. SKF-96365 disrupts SOCC activity, leading to altered intracellular calcium levels, and subsequently influencing Tcaf3's predicted transmembrane transporter binding activity and its role in regulating anion channel activity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, indirectly influencing Tcaf3 by disrupting vesicle trafficking. Dynasore impairs endocytosis, impacting the cellular trafficking of Tcaf3 and subsequently affecting its predicted positive regulation of protein targeting to the membrane and positive regulation of cell migration. | ||||||
4-Methyl-2-(1-piperidinyl)-quinoline | 5465-86-1 | sc-483337 | 25 mg | $430.00 | ||
Blocks the TMEM16A chloride channel, indirectly influencing Tcaf3 by modulating anion transport. ML204 disrupts TMEM16A activity, impacting the cellular environment and subsequently affecting Tcaf3's predicted negative regulation of anion channel activity. | ||||||
T16Ainh-A01 | 552309-42-9 | sc-497578 sc-497578A | 10 mg 50 mg | $69.00 $283.00 | ||
Inhibits the TMEM16A chloride channel, indirectly influencing Tcaf3 through modulation of anion transport. T16Ainh-A01 disrupts TMEM16A activity, impacting the cellular environment and subsequently affecting Tcaf3's predicted negative regulation of anion channel activity. | ||||||
AMG-9810 | 545395-94-6 | sc-201477 sc-201477A | 10 mg 50 mg | $86.00 $344.00 | 3 | |
Blocks the transient receptor potential cation channel subfamily V member 1 (TRPV1), indirectly impacting Tcaf3 by modulating calcium signaling. AMG-9810 disrupts TRPV1 activity, leading to altered intracellular calcium levels, and subsequently influencing Tcaf3's predicted transmembrane transporter binding activity and its role in regulating anion channel activity. | ||||||
CRAC Channel Inhibitor, BTP2 | 223499-30-7 | sc-221441 | 5 mg | $189.00 | 9 | |
Inhibits store-operated calcium channels (SOCCs), indirectly influencing Tcaf3 by modulating calcium signaling. YM-58483 disrupts SOCC activity, leading to altered intracellular calcium levels, and subsequently influencing Tcaf3's predicted transmembrane transporter binding activity and its role in regulating anion channel activity. | ||||||